European regulators approve J&J’s prostate cancer drug
Johnson & Johnson announced that the company’s investigational drug Zytiga (abiraterone acetate) has been approved by the European regulators. Zytiga
Read moreJohnson & Johnson announced that the company’s investigational drug Zytiga (abiraterone acetate) has been approved by the European regulators. Zytiga
Read more